Literature DB >> 22866121

Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism.

Alessandra Pires Duarte1, Carolina Cavaliéri Gomes, Ricardo Santiago Gomez, Fabrício Rezende Amaral.   

Abstract

A variety of diseases of the jaws may present multinucleated giant cells. These diseases include central giant cell lesions (CGCL), peripheral giant cell lesions (PGCL), brown tumor of hyperparathyroidism (BTH), and cherubism. The multinucleated giant cells in these lesions are osteoclast-like. Since NFATc1 plays a significant role in osteoclast differentiation, the present study aimed to compare the expression of NFATc1 in CGCL, PGCL, BTH and cherubism. A total of 14 formalin-fixed and paraffin-embedded tissue samples of CGCL (n=4), PGCL (n=5), BTH (n=3) and cherubism (n=2) were included in the study. An immunohistochemical analysis was performed to investigate the NFATc1 protein. The majority of giant cells in all of the cases were positive for nuclear NFATc1 and the immunostaining pattern was similar in all of the groups. Although our study supports the hypothesis that giant cell accumulation in PGCL, CGCL, BTH and cherubism is mediated by NFATc1, functional studies are required to investigate this hypothesis.

Entities:  

Year:  2011        PMID: 22866121      PMCID: PMC3410492          DOI: 10.3892/ol.2011.274

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  21 in total

1.  Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.

Authors:  Y Ueki; V Tiziani; C Santanna; N Fukai; C Maulik; J Garfinkle; C Ninomiya; C doAmaral; H Peters; M Habal; L Rhee-Morris; J B Doss; S Kreiborg; B R Olsen; E Reichenberger
Journal:  Nat Genet       Date:  2001-06       Impact factor: 38.330

2.  Treatment of a central giant cell granuloma with intralesional corticosteroid.

Authors:  Evandro Neves Abdo; Luiz César Fonseca Alves; Alessandra Sabrina Rodrigues; Ricardo Alves Mesquita; Ricardo Santiago Gomez
Journal:  Br J Oral Maxillofac Surg       Date:  2005-02       Impact factor: 1.651

3.  Cherubism - new hypotheses on pathogenesis and therapeutic consequences.

Authors:  Peter Hyckel; Alexander Berndt; Peter Schleier; Joachim H Clement; Volkmar Beensen; Hartmut Peters; Hartwig Kosmehl
Journal:  J Craniomaxillofac Surg       Date:  2005-01-12       Impact factor: 2.078

4.  A new mutation in the SH3BP2 gene showing reduced penetrance in a family affected with cherubism.

Authors:  Jan de Lange; Merel C van Maarle; Hans P van den Akker; Egbert J W Redeker
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-09-26

5.  Novel mutations in the SH3BP2 gene associated with sporadic central giant cell lesions and cherubism.

Authors:  V M Carvalho; P F Perdigão; F R Amaral; P E A de Souza; L De Marco; R S Gomez
Journal:  Oral Dis       Date:  2008-11-11       Impact factor: 3.511

6.  Nuclear factor of activated T cells (NFAT) is a possible target for dexamethasone in thymocyte apoptosis.

Authors:  M Wisniewska; M Stanczyk; B Grzelakowska-Sztabert; B Kaminska
Journal:  Cell Biol Int       Date:  1997-03       Impact factor: 3.612

7.  Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.

Authors:  S M Bell; M Shaw; Y S Jou; R M Myers; M A Knowles
Journal:  Genomics       Date:  1997-09-01       Impact factor: 5.736

8.  Intralesional corticosteroid injection for treatment of central giant-cell granuloma.

Authors:  M C Adornato; K A Paticoff
Journal:  J Am Dent Assoc       Date:  2001-02       Impact factor: 3.634

Review 9.  Peripheral giant cell granuloma. Clinicopathologic study of 224 new cases and review of 956 reported cases.

Authors:  N Katsikeris; E Kakarantza-Angelopoulou; A P Angelopoulos
Journal:  Int J Oral Maxillofac Surg       Date:  1988-04       Impact factor: 2.789

Review 10.  Glucocorticoids and the osteoclast.

Authors:  Hyun-Ju Kim; Haibo Zhao; Hideki Kitaura; Sandip Bhattacharyya; Judson A Brewer; Louis J Muglia; F Patrick Ross; Steven L Teitelbaum
Journal:  Ann N Y Acad Sci       Date:  2007-11       Impact factor: 5.691

View more
  6 in total

1.  Quantitative expression analysis of apoptotic/antiapoptotic genes and association with immunolocalization of BAX and BCL-2 in peripheral and central giant cell lesions of the jaws.

Authors:  Fabrício Rezende Amaral; Vanessa Fátima Bernardes; Alessandra Pires Duarte; Núbia Braga Pereira; Anilton César Vasconcelos; Ricardo Santiago Gomez; Carolina Cavaliéri Gomes
Journal:  Tumour Biol       Date:  2011-06-25

Review 2.  Modeling craniofacial and skeletal congenital birth defects to advance therapies.

Authors:  Cynthia L Neben; Ryan R Roberts; Katrina M Dipple; Amy E Merrill; Ophir D Klein
Journal:  Hum Mol Genet       Date:  2016-06-26       Impact factor: 6.150

3.  Peripheral giant cell granuloma: This enormity is a rarity.

Authors:  Silvia Victor Rodrigues; Dipika Kalyan Mitra; Sudarshana Devendrasing Pawar; Harshad Narayan Vijayakar
Journal:  J Indian Soc Periodontol       Date:  2015 Jul-Aug

4.  Molecular and cellular characterizations of human cherubism: disease aggressiveness depends on osteoclast differentiation.

Authors:  Natacha Kadlub; Quentin Sessiecq; Marion Mandavit; Aurore Coulomb L'Hermine; Cecile Badoual; Louise Galmiche; Ariane Berdal; Vianney Descroix; Arnaud Picard; Amélie E Coudert
Journal:  Orphanet J Rare Dis       Date:  2018-09-20       Impact factor: 4.123

5.  Hyperparathyroidism: Unusual location of brown tumors.

Authors:  Alia Fazaa; Yasmine Makhlouf; Soussen Miladi; Mariem Sellami; Kmar Ouenniche; Leila Souebni; Selma Kassab; Selma Chekili; Kawther Ben Abdelghani; Ahmed Laatar
Journal:  Clin Case Rep       Date:  2022-02-03

6.  A Comparative Study of Cathepsin D Expression in Peripheral and Central Giant Cell Granuloma of the Jaws by Immunohistochemistry Technique.

Authors:  Massoumeh Zargaran; Abbas Moghimbeigi; Noushin Afsharmoghadam; Mohsen Nasr Isfahani; Atefeh Hashemi
Journal:  J Dent (Shiraz)       Date:  2016-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.